ADVFN - Advanced Financial Network.
Free Real-time News Alerts: Tell us which stocks you're watching and we'll send you the latest news as it is released direct to your e-mail.
News alerts
HOME» NYSE » V » VRX Stock Price

Valeant Pharma Stock Price

 Valeant Pharmaceuticals International Stock Price
VRX Stock Price
 Valeant Pharmaceuticals International Stock Chart
VRX Stock Chart
 Valeant Pharmaceuticals International Stock News
VRX Stock News
 Valeant Pharmaceuticals International Company Information
VRX Company Information
 Valeant Pharmaceuticals International Stock Trades
VRX Stock Trades
Valeant Pharma (VRX)
URL : Valeant Pharma
20.27 VRX 0.00
0.00 (0.00%)

Company Description : A multinational specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products.

Valeant Pharma Stock
Share Price20.27
Bid Price-
Ask Price-
% Change0.00%
Last Change Time08:50:43
Yesterday's Close20.27
Valeant Pharma Stock Chart
June 2015 to June 2016
Valeant Pharmaceuticals International Historical Stock Chart June 2015 to June 2016
More VRX Stock Trades »Valeant Pharma : Stock Trades Table
TimePriceSizeTypeBid PriceOffer PriceNumberBuy / Sell
08:50:4319.95115form t19.9419.97426S
08:50:2319.9550form t19.9119.97425B
08:50:2019.95200form t19.9119.97424B
08:49:3819.9710form t19.9119.97423B
08:48:3319.95500form t19.9119.97422B
08:48:3019.9320form t19.9119.97421S
08:48:3019.93100form t19.9119.97420S
08:48:2419.9725form t19.9119.97419B
08:46:2819.98125form t19.9119.98418B
08:45:4519.93100form t19.9119.98417S
Live Intraday Valeant Pharma Stock Quote
Monday, 27 June 2016
Valeant Pharmaceuticals International Intraday Stock Chart Monday, 27 June 2016

Valeant Pharma and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations